Targeting plasticity pathways for novel therapy in prostate cancer

Targeting plasticity pathways for novel therapy in prostate cancer

VJOncology

1 year
286 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
From the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA, Andrew Armstrong, MD, from Duke University, Durham, NC, highlights the need for novel therapies targeting plasticity pathways in particular, in order to treat bone metastases in patients with prostate cancer. Dr Armstrong also outlines potential predictive biomarkers, including DNA defects in PARP inhibitors and androgen receptor defects.
Up Next Autoplay
BOPA18__VJO_Rachel Elliott_01
BOPA18__VJO_Rachel Elliott_01
Category: Acute Lymphoblastic Leukemia
0 Views
VJOncology 1 year
New models for patient care: advanced pharmacy practitioners
New models for patient care: advanced pharmacy practitioners
Category: General
820 Views
VJOncology 1 year
Patient symptom and experience trackers
Patient symptom and experience trackers
Category: General
587 Views
VJOncology 1 year
Update from the Scottish Cancer Medicines Outcome Programme
Update from the Scottish Cancer Medicines Outcome Programme
Category: General
581 Views
VJOncology 1 year
The switch to biosimilar rituximab at UCH: 12 months on
The switch to biosimilar rituximab at UCH: 12 months on
Category: Lymphoma
562 Views
VJOncology 1 year
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
Category: General
368 Views
VJOncology 1 year
Visibility of Oncology Pharmacists to patients
Visibility of Oncology Pharmacists to patients
Category: Other
263 Views
VJOncology 1 year
Smart app to allow patients to manage their side effects independently
Smart app to allow patients to manage their side effects independently
Category: Breast Cancer
80 Views
VJOncology 1 year
cancer-druginteractions.org: a comprehensive tool for HCPs
cancer-druginteractions.org: a comprehensive tool for HCPs
Category: Other
39 Views
VJOncology 1 year
The emergence of mixed speciality oncology
The emergence of mixed speciality oncology
Category: Other
67 Views
VJOncology 1 year